Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1

Conditions

Stomach Neoplasms 2Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Taurine × Gastrointestinal × Clear all
NCT03550885 2026-04-06

Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

University of Illinois at Chicago

Phase NA Completed
15 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06128252 2025-01-07

Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer

Tang-Du Hospital

Phase NA Recruiting
96 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06123455 2023-11-08

Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

Tang-Du Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡